Abstract
Immediate efficacy of percutaneous transhepatic obliteration and sclerotherapy for giant pipeline esophageal varices hemorrhage in a patient with liver cirrhosis type C
Highlights
Percutaneous transhepatic obliteration (PTO) was firstly reported by Lunderquist in 1974 [2]
A 5‐French gauge sheath catheter was introduced into the portal vein
A coaxial catheter was inserted into these feeding veins while avoiding the main feeding vein
Summary
PTO was firstly reported by Lunderquist in 1974 [2]. This treatment had been widely performed as an emergency measure in cases of variceal hemorrhage [2]. A 49-year-old man was referred to us with a diagnosis of hematemesis by giant pipeline esophageal varices due to liver cirrhosis hepatitis C infection after carving a tattoo at 20-year age (Figures 1A & 1B). Endoscopic injection sclerotherapy (EIS) was generally treated esophageal varices.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
